D.E. Shaw & Co’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $115M | Buy |
2,267,800
+401,200
| +21% | +$18.7M | 0.09% | 327 |
|
|
2025
Q4 | $55M | Buy |
1,866,600
+490,100
| +36% | +$13.3M | 0.04% | 663 |
|
|
2025
Q3 | $35.6M | Buy |
1,376,500
+339,700
| +33% | +$9.48M | 0.03% | 832 |
|
|
2025
Q2 | $28.6M | Buy |
1,036,800
+802,500
| +343% | +$21.1M | 0.03% | 832 |
|
|
2025
Q1 | $6.64M | Sell |
234,300
-433,300
| -65% | -$15.4M | 0.01% | 1692 |
|
|
2024
Q4 | $27.8M | Sell |
667,600
-10,000
| -1% | -$478K | 0.03% | 845 |
|
|
2024
Q3 | $45.3M | Sell |
677,600
-101,500
| -13% | -$9.32M | 0.06% | 556 |
|
|
2024
Q2 | $92.5M | Sell |
779,100
-4,400
| -0.6% | -$557K | 0.13% | 274 |
|
|
2024
Q1 | $83.5M | Buy |
783,500
+87,100
| +13% | +$8.78M | 0.11% | 311 |
|
|
2023
Q4 | $69.3M | Buy |
696,400
+64,100
| +10% | +$5.39M | 0.1% | 375 |
|
|
2023
Q3 | $65.3M | Buy |
632,300
+248,700
| +65% | +$27.7M | 0.11% | 341 |
|
|
2023
Q2 | $46.6M | Sell |
383,600
-25,900
| -6% | -$3.46M | 0.07% | 464 |
|
|
2023
Q1 | $62.9M | Buy |
409,500
+146,700
| +56% | +$24.2M | 0.1% | 353 |
|
|
2022
Q4 | $47.2M | Buy |
262,800
+146,500
| +126% | +$24M | 0.08% | 456 |
|
|
2022
Q3 | $13.8M | Sell |
116,300
-208,900
| -64% | -$31.7M | 0.02% | 1105 |
|
|
2022
Q2 | $46.5M | Buy |
325,200
+188,900
| +139% | +$27M | 0.08% | 431 |
|
|
2022
Q1 | $23.5M | Sell |
136,300
-75,100
| -36% | -$12.6M | 0.03% | 922 |
|
|
2021
Q4 | $53.7M | Sell |
211,400
-50,500
| -19% | -$14.8M | 0.07% | 507 |
|
|
2021
Q3 | $101M | Sell |
261,900
-100,800
| -28% | -$37.2M | 0.13% | 253 |
|
|
2021
Q2 | $85.2M | Sell |
362,700
-131,200
| -27% | -$23.4M | 0.1% | 318 |
|
|
2021
Q1 | $64.7M | Buy |
493,900
+450,300
| +1,033% | +$65.3M | 0.08% | 378 |
|
|
2020
Q4 | $4.55M | Sell |
43,600
-21,900
| -33% | -$2.22M | 0.01% | 1949 |
|
|
2020
Q3 | $4.63M | Buy |
65,500
+50,400
| +334% | +$3.51M | 0.01% | 1759 |
|
|
2020
Q2 | $970K | Buy |
+15,100
| New | +$827K | ﹤0.01% | 2963 |
|
Other funds holding MRNA
VCM
VPM
